National Database of the Virtual Institute of Cerebrovascular Diseases

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Jun 27, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding cerebrovascular diseases, which are conditions affecting the blood vessels in the brain. The main goal is to create a national database that helps identify different types of these diseases and how they impact patients' health. Researchers will also look for signs in medical tests that can help predict how well a patient might do over time and if they might face complications from treatments. Importantly, patients who join this study will not have to undergo any extra medical procedures beyond what they typically receive in their regular care.

To be eligible for this study, participants must have a diagnosis of cerebrovascular disease, which includes conditions where parts of the brain are affected by restricted blood flow or bleeding. They will need to provide consent, or have someone else, like a parent or legal representative, provide it for them if they are unable to. Those who are interested in participating should know that the study is not yet recruiting, and they can expect their medical information to be collected without any additional tests or treatments required.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of cerebrovascular pathology defined according to the NINDS special report of 1990 as "all disorders in which there is an area of the brain transiently or permanently affected by ischemia or bleeding and/or in which one or more blood vessels of the brain are mainly altered by a pathological process", falling within the following codes of the International Classification of Diseases, 9th revision (ICD-9): ICD-9 430-438;
• • Informed consent provided by the patient or his legal representative in the case of mental incapacity or by the parents/guardians in the case of minors.
• Exclusion Criteria:
• • The patient, his legal representative in the case of mental incapacity or his parents/guardians in the case of minors clearly state their will to leave the study;
• • Onset of cerebrovascular disease before January 1, 2016.